4P41.F SURGICAL SCIENCE SWEDEN
- Market cap
- EUR 284M
- P/E
- 32.8x
- P/B
- 0.69x
- ROE
- 1.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4P41.F undervalued?
Graham number4P41.F trades 0.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SURGICAL SCIENCE SWEDEN fundamental analysis
No fundamental analysis for SURGICAL SCIENCE SWEDEN yet.
SURGICAL SCIENCE SWEDEN stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SURGICAL SCIENCE SWEDEN
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mento…
Full company profileSURGICAL SCIENCE SWEDEN financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SURGICAL SCIENCE SWEDEN annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 367M | 803M | 883M | 884M | 992M | 980M |
| Gross Profit | 266M | 532M | 613M | 598M | 658M | 663M |
| Operating Income | 56.5M | 163M | 189M | 144M | 68.9M | 111M |
| EBITDA | - | 261M | 325M | 224M | 190M | 111M |
| Net Income | 86.2M | 188M | 234M | 132M | 66.8M | 79.0M |
| EPS | 1.70 | 3.70 | 4.59 | 2.58 | 1.31 | 1.55 |
| Balance Sheet | ||||||
| Total Assets | 3.98B | 4.65B | 4.70B | 5.48B | 4.69B | 4.97B |
| Total Liabilities | 393M | 413M | 357M | 651M | 418M | 420M |
| Shareholders' Equity | 3.59B | 4.24B | 4.35B | 4.83B | 4.27B | 4.55B |
| Cash & Short-term Investments | 317M | 434M | 634M | 968M | 616M | 658M |
| Cash Flow | ||||||
| Operating Cash Flow | 39.1M | 129M | 238M | 137M | 79.8M | 161M |
| Capital Expenditure | 14.4M | 34.5M | 44.1M | 47.5M | 49.3M | 79.5M |
| Free Cash Flow | 24.7M | 94.9M | 194M | 89.7M | 30.5M | 81.7M |
| Ratios | ||||||
| ROE | 2.4% | 4.4% | 5.4% | 2.7% | 1.6% | 1.7% |
| ROA | 2.2% | 4.0% | 5.0% | 2.4% | 1.4% | 1.6% |
| Net Profit Margin | 23.5% | 23.4% | 26.5% | 14.9% | 6.7% | 8.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SURGICAL SCIENCE SWEDEN dividends
SURGICAL SCIENCE SWEDEN has not paid dividends in the last 5 fiscal years.
Who owns SURGICAL SCIENCE SWEDEN
- Insiders 29.35%
- Institutions 34.23%
- Public & others 36.42%
- Shares outstanding 51.0M
- Free float 37.1M
SURGICAL SCIENCE SWEDEN company profile
- Company name
- SURGICAL SCIENCE SWEDEN
- Ticker
- 4P41.F
- ISIN
- SE0014428512
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 319
- Fiscal year end
- December
- Address
- Drakegatan 7A, Gothenburg, Sweden, 412 50
- Phone
- 46 3 17 41 65 60
- Website
- surgicalscience.com
About SURGICAL SCIENCE SWEDEN
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.
SURGICAL SCIENCE SWEDEN management
10- Mr. Tom EnglundChief Executive Officer · born 1976
- Mr. Anders LarssonCo-Founder & CTO · born 1973
- Ms. Anna AhlbergChief Financial Officer · born 1970
- Mr. Boaz Tal ), Adv. (CPA, C.P.A.Chief Operating Officer · born 1968
- Adele HornIR Manager
- Mr. Martin JanssonHead of Global Sales · born 1971
- Ms. Inbal Mazor-BadichiChief Product & Marketing Officer · born 1969
- Mr. Daniel EvestedtHead of Development · born 1977
- Mr. Jeffrey Berkley Ph.D.Chief Innovation Officer · born 1969
- Mr. Doron ZilbermanExecutive Vice President of International Sales & Educational Products · born 1962